UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000034591
Receipt number R000039427
Scientific Title Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malignant pleural effusion -phase II trial-
Date of disclosure of the study information 2018/10/24
Last modified on 2020/04/23 14:17:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malignant pleural effusion -phase II trial-

Acronym

Carboplatin + nab-Paclitaxel treatment for malignant pleural effusion

Scientific Title

Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malignant pleural effusion -phase II trial-

Scientific Title:Acronym

Carboplatin + nab-Paclitaxel treatment for malignant pleural effusion

Region

Japan


Condition

Condition

Non-small lung cancer

Classification by specialty

Pneumology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Efficacy and safety of Carboplatin + nab-Paclitaxel treatment for non-small lung cancer with malingnant pleural effusion

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

Control rate for malignant pleural effusion

Key secondary outcomes

RR, PFS, OS
Safety, one-year survival rate
Time for increase of pleural effusion
Rate of patients who did not require pleurodesis


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

CBDCA + nab-Paclitaxel

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically proven non-small lung cancer
2) Histologically proven malignant effusion
3) Age over 20-years old
4) Performance status (ECOG) = 0-2
5) Never used of anti-cancer treatment except for either kinase treatment or immuno-check point inhibitor
6) Eligible for adjuvant or relapse after surgical treatment
7) Surgical treatment after 6 weeks
8) Adjuvant treatment after one-year
9) Adequate organ functions
10) Patients who have estimated life expectancy longer than 12 weeks
11) Written informed consent

Key exclusion criteria

1) Allergy for either nab-Paclitaxel or Paclitaxel
2) Severe complications such as intersitial pneumonia, CHF, CRF, liver damage, uncontrolled DM or HT
3) Symptomatic brain metastasis
4) Need for dainage
5) History of pleurodesis
6) Surgical treatment within 2 weeks
7) Active infection
8) Active multiple malignancy
9) Uncontrolled mental sympotoms
10) Pregnancy or pregnant possibiltiy
11) Administration of corticosteroids
12) Patients whom doctor consider ineligible

Target sample size

25


Research contact person

Name of lead principal investigator

1st name Masaki
Middle name
Last name Fujita

Organization

Fukuoka University, Facutly of Medicine

Division name

Department of Respiratory Medicine

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonanku, Fukuoka

TEL

0928011011

Email

mfujita@fukuoka-u.ac.jp


Public contact

Name of contact person

1st name Fumiyasu
Middle name
Last name Igata

Organization

Fukuoka University, Facutly of Medicine

Division name

Department of Respiratory Medicine

Zip code

814-0180

Address

7-45-1 Nanakuma, Jonanku, Fukuoka

TEL

0928011011

Homepage URL


Email

figata@fukuoka-u.ac.jp


Sponsor or person

Institute

Fukuoka University, Facutly of Medicine,
Department of Respiratory Medicine

Institute

Department

Personal name



Funding Source

Organization

Fukuoka University, Facutly of Medicine,
Department of Respiratory Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

JAPAN


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Fukuoka University - Medical Ethics Review Board

Address

7-45-1 Nanakuma, Jonanku, Fukuoka

Tel

0928011011

Email

cawati@fukuoka-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

福岡大学西新病院(福岡県)、福岡大学筑紫病院(福岡県)、福岡徳洲会病院(福岡県)、福西会病院(福岡県)


Other administrative information

Date of disclosure of the study information

2018 Year 10 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results

Registration is not expected.

Results date posted

2020 Year 04 Month 23 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2018 Year 10 Month 16 Day

Anticipated trial start date

2018 Year 11 Month 01 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 10 Month 22 Day

Last modified on

2020 Year 04 Month 23 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000039427


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name